After recalls, Merck sells out of J&J OTC venture for $175M - FiercePharma
Links shared publicly online about this topic.
- 0total visits
After recalls, Merck sells out of J&J OTC venture for $175M - FiercePharma
Merck ($MRK) is stepping out of a consumer-drugs partnership with Johnson & Johnson ($JNJ). After quality issues at one of the 50-50 joint venture's plants spurred recalls of Pepcid and Mylanta Read more...
View full resource at fiercepharma.com
Tags: Joint, Johnson & Johnson, Merck & Co.
Most Recently Shared on September 29, 2011 at 8:53 pm By:
Merck exits J&J joint venture after PA plant problems--including consent decree--and Pepcid recalls http://t.co/1LFFpKMG $MRK
Advertisement
